Connection

Andrew Goodwin to Anticoagulants

Back to Details
This is a "connection" page, showing publications Andrew Goodwin has written about Anticoagulants.
Andrew Goodwin
Connection Strength
0.078
Anticoagulants
  1. Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban. Arch Pathol Lab Med. 2022 01 02; 146(2):145-153.
    View in: PubMed
    Score: 0.039
  2. Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma. J Thromb Thrombolysis. 2022 Feb; 53(2):479-484.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.